Functional characterization of novel melanocortin-3 receptor mutations identified from obese subjects

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1772, Issue 10, 2007, Pages 1167-1174

  Tao, Ya Xiong ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

G protein coupled receptor; Melanocortin 3 receptor; Mutation; Obesity; Trafficking

Indexed keywords

MELANOCORTIN 3 RECEPTOR;

ARTICLE; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENE MUTATION; HUMAN; HUMAN CELL; LIGAND BINDING; MUTAGENESIS; OBESITY; PRIORITY JOURNAL;

AMINO ACID MOTIFS; AMINO ACID SUBSTITUTION; CELL LINE; GENE EXPRESSION; HUMANS; LIGANDS; MUTATION, MISSENSE; OBESITY; PROTEIN BINDING; RECEPTOR, MELANOCORTIN, TYPE 3; SIGNAL TRANSDUCTION;

EID: 36649035294     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2007.09.002     Document Type: Article

References (40)

1. Gantz I., Miwa H., Konda Y., Shimoto Y., Tashiro T., Watson S.J., DelValle J., and Yamada T. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J. Biol. Chem. 268 (1993) 15174-15179
2. Gantz I., Konda Y., Tashiro T., Shimoto Y., Miwa H., Munzert G., Watson S.J., DelValle J., and Yamada T. Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 268 (1993) 8246-8250
3. Roselli-Rehfuss L., Mountjoy K.G., Robbins L.S., Mortrud M.T., Low M.J., Tatro J.B., Entwistle M.L., Simerly R.B., and Cone R.D. Identification of a receptor for γ melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 8856-8860
4. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., Smith F.J., Campfield L.A., Burn P., and Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88 (1997) 131-141
5. Chen A.S., Marsh D.J., Trumbauer M.E., Frazier E.G., Guan X.M., Yu H., Rosenblum C.I., Vongs A., Feng Y., Cao L., Metzger J.M., Strack A.M., Camacho R.E., Mellin T.N., Nunes C.N., Min W., Fisher J., Gopal-Truter S., MacIntyre D.E., Chen H.Y., and Van der Ploeg L.H. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 26 (2000) 97-102
6. Butler A.A., Kesterson R.A., Khong K., Cullen M.J., Pelleymounter M.A., Dekoning J., Baetscher M., and Cone R.D. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141 (2000) 3518-3521
7. Zhang Y., Kilroy G.E., Henagan T.M., Prpic-Uhing V., Richards W.G., Bannon A.W., Mynatt R.L., and Gettys T.W. Targeted deletion of melanocortin receptor subtypes 3 and 4, but not CART, alters nutrient partitioning and compromises behavioral and metabolic responses to leptin. FASEB J. 19 (2005) 1482-1491
8. Li W.D., Joo E.J., Furlong E.B., Galvin M., Abel K., Bell C.J., and Price R.A. Melanocortin 3 receptor (MC3R) gene variants in extremely obese women. Int. J. Obe. Relat. Metab. Disord. 24 (2000) 206-210
9. Hani E.H., Dupont S., Durand E., Dina C., Gallina S., Gantz I., and Froguel P. Naturally occurring mutations in the melanocortin receptor 3 gene are not associated with type 2 diabetes mellitus in French Caucasians. J. Clin. Endocrinol. Metab. 86 (2001) 2895-2898
10. Wong J., Love D.R., Kyle C., Daniels A., White M., Stewart A.W., Schnell A.H., Elston R.C., Holdaway I.M., and Mountjoy K.G. Melanocortin-3 receptor gene variants in a Maori kindred with obesity and early onset type 2 diabetes. Diabetes Res. Clin. Pract. 58 (2002) 61-71
11. Schalin-Jantti C., Valli-Jaakola K., Oksanen L., Martelin E., Laitinen K., Krusius T., Mustajoki P., Heikinheimo M., and Kontula K. Melanocortin-3-receptor gene variants in morbid obesity. Int. J. Obes. Relat. Metab. Disord. 27 (2003) 70-74
12. Lembertas A.V., Perusse L., Chagnon Y.C., Fisler J.S., Warden C.H., Purcell-Huynh D.A., Dionne F.T., Gagnon J., Nadeau A., Lusis A.J., and Bouchard C. Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J. Clin. Invest. 100 (1997) 1240-1247
13. Zouali H., Hani E.H., Philippi A., Vionnet N., Beckmann J.S., Demenais F., and Froguel P. A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. Hum. Mol. Genet. 6 (1997) 1401-1408
14. Ji L., Malecki M., Warram J.H., Yang Y., Rich S.S., and Krolewski A.S. New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes 46 (1997) 876-881
15. Bowden D.W., Sale M., Howard T.D., Qadri A., Spray B.J., Rothschild C.B., Akots G., Rich S.S., and Freedman B.I. Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes 46 (1997) 882-886
16. Ghosh S., Watanabe R.M., Hauser E.R., Valle T., Magnuson V.L., Erdos M.R., Langefeld C.D., Balow Jr. J., Ally D.S., Kohtamaki K., Chines P., Birznieks G., Kaleta H.S., Musick A., Te C., Tannenbaum J., Eldridge W., Shapiro S., Martin C., Witt A., So A., Chang J., Shurtleff B., Porter R., Kudelko K., Unni A., Segal L., Sharaf R., Blaschak-Harvan J., Eriksson J., Tenkula T., Vidgren G., Ehnholm C., Tuomilehto-Wolf E., Hagopian W., Buchanan T.A., Tuomilehto J., Bergman R.N., Collins F.S., and Boehnke M. Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 2198-2203
17. Lee Y.S., Poh L.K., and Loke K.Y. A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. J. Clin. Endocrinol. Metab. 87 (2002) 1423-1426
18. Tao Y.X., and Segaloff D.L. Functional characterization of melanocortin-3 receptor variants identify a loss-of-function mutation involving an amino acid critical for G protein-coupled receptor activation. J. Clin. Endocrinol. Metab. 89 (2004) 3936-3942
19. Rached M., Buronfosse A., Begeot M., and Penhoat A. Inactivation and intracellular retention of the human I183N mutated melanocortin 3 receptor associated with obesity. Biochim. Biophys. Acta 1689 (2004) 229-234
20. Lee Y.S., Poh L.K., Kek B.L., and Loke K.Y. The role of melanocortin 3 receptor gene in childhood obesity. Diabetes 56 (2007) 2622-2630
21. Mencarelli M., Maestrini S., Tagliaferri M., Brunani A., Petroni M.L., Liuzzi A., and DiBlasio A.M. The Endocrine Society's 86th Annual Meeting (2004) 140
22. Tao Y.X., and Segaloff D.L. Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity. Endocrinology 144 (2003) 4544-4551
23. Chen C., and Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7 (1987) 2745-2752
24. Sawyer T.K., Sanfilippo P.J., Hruby V.J., Engel M.H., Heward C.B., Burnett J.B., and Hadley M.E. 4-Norleucine, 7-d-phenylalanine-α-melanocyte-stimulating hormone: a highly potent α-melanotropin with ultralong biological activity. Proc. Natl. Acad. Sci. U. S. A. 77 (1980) 5754-5758
25. Tao Y.X. Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity. Mol. Cell. Endocrinol. 239 (2005) 1-14
26. Tao Y.X. Inactivating mutations of G protein-coupled receptors and diseases: structure-function insights and therapeutic implications. Pharmacol. Ther. 111 (2006) 949-973
27. Lubrano-Berthelier C., Durand E., Dubern B., Shapiro A., Dazin P., Weill J., Ferron C., Froguel P., and Vaisse C. Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations. Hum. Mol. Genet. 12 (2003) 145-153
28. Yeo G.S., Lank E.J., Farooqi I.S., Keogh J., Challis B.G., and O'Rahilly S. Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms. Hum. Mol. Genet. 12 (2003) 561-574
29. Nijenhuis W.A., Garner K.M., VanRozen R.J., and Adan R.A. Poor cell surface expression of human melanocortin-4 receptor mutations associated with obesity. J. Biol. Chem. 278 (2003) 22939-22945
30. Beaumont K.A., Newton R.A., Smit D.J., Leonard J.H., Stow J.L., and Sturm R.A. Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk. Hum. Mol. Genet. 14 (2005) 2145-2154
31. Feng N., Young S.F., Aguilera G., Puricelli E., Adler-Wailes D.C., Sebring N.G., and Yanovski J.A. Co-occurrence of two partially inactivating polymorphisms of MC3R is associated with pediatric-onset obesity. Diabetes 54 (2005) 2663-2667
32. Cone R.D. Haploinsufficiency of the melanocortin-4 receptor: part of a thrifty genotype?. J. Clin. Invest. 106 (2000) 185-187
33. Tao Y.X., and Segaloff D.L. Functional analyses of melanocortin-4 receptor mutations identified from patients with binge eating disorder and nonobese or obese subjects. J. Clin. Endocrinol. Metab. 90 (2005) 5632-5638
34. Rong R., Tao Y.X., Cheung B.M., Xu A., Cheung G.C., and Lam K.S. Identification and functional characterization of three novel human melanocortin-4 receptor gene variants in an obese Chinese population. Clin. Endocrinol. 65 (2006) 198-205
35. Hinney A., Bettecken T., Tarnow P., Brumm H., Reichwald K., Lichtner P., Scherag A., Nguyen T.T., Schlumberger P., Rief W., Vollmert C., Illig T., Wichmann H.E., Schafer H., Platzer M., Biebermann H., Meitinger T., and Hebebrand J. Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany. J. Clin. Endocrinol. Metab. 91 (2006) 1761-1769
36. Gales C., Kowalski-Chauvel A., Dufour M.N., Seva C., Moroder L., Pradayrol L., Vaysse N., Fourmy D., and Silvente-Poirot S. Mutation of Asn-391 within the conserved NPXXY motif of the cholecystokinin B receptor abolishes Gq protein activation without affecting its association with the receptor. J. Biol. Chem. 275 (2000) 17321-17327
37. 5,6F motif in the rhodopsin ground state and during activation. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2290-2295
38. Kalatskaya I., Schussler S., Blaukat A., Muller-Esterl W., Jochum M., Proud D., and Faussner A. Mutation of tyrosine in the conserved NPXXY sequence leads to constitutive phosphorylation and internalization, but not signaling, of the human B2 bradykinin receptor. J. Biol. Chem. 279 (2004) 31268-31276
39. Bessant D.A., Khaliq S., Hameed A., Anwar K., Payne A.M., Mehdi S.Q., and Bhattacharya S.S. Severe autosomal dominant retinitis pigmentosa caused by a novel rhodopsin mutation (Ter349Glu). Mutations in brief no. 208. Online. Hum. Mutat. 13 (1999) 83
40. Seminara S.B., Messager S., Chatzidaki E.E., Thresher R.R., Acierno Jr. J.S., Shagoury J.K., Bo-Abbas Y., Kuohung W., Schwinof K.M., Hendrick A.G., Zahn D., Dixon J., Kaiser U.B., Slaugenhaupt S.A., Gusella J.F., O'Rahilly S., Carlton M.B., Crowley Jr. W.F., Aparicio S.A., and Colledge W.H. The GPR54 gene as a regulator of puberty. N. Engl. J. Med. 349 (2003) 1614-1627